Abstract: Presented are ways to address the problem of replication competent adenovirus in adenoviral production for use with, for example, gene therapy. Packaging cells having no overlapping sequences with a selected vector and are suited for large scale production of recombinant adenoviruses. A method of the invention produces adenovirus incapable of replicating. The method includes a primary cell containing a nucleic acid based on or derived from adenovirus and an isolated recombinant nucleic acid molecule for transfer into the primary cell. The isolated recombinant nucleic acid molecule is based on or derived from an adenovirus, and further has at least one functional encapsidating signal, and at least one functional Inverted Terminal Repeat. The isolated recombinant nucleic acid molecule lacks overlapping sequences with the nucleic acid of the cell.
Type:
Grant
Filed:
June 15, 1999
Date of Patent:
October 23, 2001
Assignees:
IntroGene B.V., Rijksuniversiteit
Inventors:
Frits Jacobus Fallaux, Robert Cornelis Hoeben, Alex Jan Van Der Eb, Abraham Bout, Domenico Valerio
Abstract: Disclosed is substantially pure DNA encoding a crucifer ACC synthase polypeptide; a promoter functional in immature plant tissues which is capable of ethylene induction; and methods of using such promoters to express recombinant proteins or RNA and to regulate ethylene-inducible events of a plant, e.g., fruit ripening or senescence, especially during early stages of plant development.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
June 1, 1999
Assignees:
The General Hospital Corporation, Rijksuniversiteit
Inventors:
Dominique Van Der Straeten, Howard Goodman, Marc Van Montagu